Correction to: IL-39 acts as a friend to pancreatic cancer

Alicia A Manning; Lei Zhao; Ziwen Zhu; Huaping Xiao; Chase G Redington; Vivi A Ding; Theodore Stewart-Hester; Qian Bai; Jacob Dunlap; Mark R Wakefield; Yujiang Fang

doi:10.1007/s12032-018-1244-y

Correction to: IL-39 acts as a friend to pancreatic cancer

Med Oncol. 2019 Jan 22;36(2):22. doi: 10.1007/s12032-018-1244-y.

Authors

Affiliations

¹ Department of Microbiology & Immunology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA.
² Department of Respiratory Medicine, The 2nd People's Hospital of Hefei and Hefei Hospital Affiliated to Anhui Medical University, Hefei, China.
³ Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
⁴ Department of Microbiology & Immunology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA. yujiang.fang@dmu.edu.
⁵ Department of Surgery, University of Missouri School of Medicine, Columbia, MO, 65212, USA. yujiang.fang@dmu.edu.
⁶ Department of Microbiology, Immunology & Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA. yujiang.fang@dmu.edu.

PMID: 30671681
DOI: 10.1007/s12032-018-1244-y

Abstract

The original version of this article unfortunately contained a mistake in the text of the entire article. The word "IL-39" should read as "meteorin-like protein". This has been corrected with this correction.

Publication types

Published Erratum